Loading resource…

University of Münster, European Foundation for Study of Chronic Liver Failure, University of Southern Denmark, Yale University, VA-CT Healthcare System
Albumin is a crucial protein synthesized by the liver, and its levels are often reduced in liver diseases such as cirrhosis. The document explores the pathophysiological relevance of intravenous albumin administration, particularly in advanced cirrhosis, and raises critical questions regarding the optimal use of albumin in various clinical scenarios. It reviews recent studies and trials, highlighting the need for refined dosing and administration strategies to maximize patient outcomes while minimizing risks.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

ACUTE PANCREATITIS: MECHANISMS AND THERAPEUTIC APPROACHES
Same clinical topic · Gastroenterology

Functional Dyspepsia
Same clinical topic · Gastroenterology

AGA CLINICAL PRACTICE UPDATE ON EVALUATION AND MANAGEMENT OF REFRACTORY CONSTIPATION: EXPERT REVIEW
Same clinical topic · Gastroenterology

AGA CLINICAL PRACTICE UPDATE ON MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN ADULTS: EXPERT REVIEW
Same clinical topic · Gastroenterology

CURRENT APPROACH TO DIAGNOSIS AND MANAGEMENT OF LOW-PHOSPHOLIPID ASSOCIATED CHOLELITHIASIS SYNDROME
Same clinical topic · Gastroenterology

PRIMER Ulcerative colitis
Same clinical topic · Gastroenterology

PRIMER CROHN’S DISEASE
Same clinical topic · Gastroenterology

UNCOMPLICATED CHOLEDOCHOLITHIASIS IN ELDERLY PATIENTS: A TARGET TRIAL EMULATION COMPARING OBSERVATION AND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
Same clinical topic · Gastroenterology

CELIAC DISEASE
Same clinical topic · Gastroenterology